Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Journal of Medicinal Chemistry
|
November 18, 2009
Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors
Arie Zask, Joshua Kaplan, Jeroen C Verheijen, et al.
Journal of Medicinal Chemistry
|
August 12, 2008
Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine
João Neres, Nicholas P Labello, Ravindranadh V Somu, et al.
Mabs
|
November 26, 2022
Reduction of therapeutic antibody self-association using yeast-display selections and machine learning
Emily K Makowski, Hongwei Chen, Matthew Lambert, et al.
Chemistry & Biology
|
January 1, 2004
Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system
Eric M Bennett, Ruchi Anand, Paula W Allan, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2014
Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
L Nathan Tumey, Diane H Boschelli, Niala Bhagirath, et al.
Plos One
|
May 8, 2020
Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design
James R Apgar, Amy S P Tam, Rhady Sorm, et al.
The AAPS Journal
|
April 26, 2017
Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates
L Nathan Tumey, Fengping Li, Brian Rago, et al.
Molecular Cancer Therapeutics
|
August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers
Edmund I Graziani, Matthew Sung, Dangshe Ma, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Journal of Medicinal Chemistry
|
November 18, 2009
Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors
Arie Zask, Joshua Kaplan, Jeroen C Verheijen, et al.
Journal of Medicinal Chemistry
|
August 12, 2008
Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine
João Neres, Nicholas P Labello, Ravindranadh V Somu, et al.
Mabs
|
November 26, 2022
Reduction of therapeutic antibody self-association using yeast-display selections and machine learning
Emily K Makowski, Hongwei Chen, Matthew Lambert, et al.
Chemistry & Biology
|
January 1, 2004
Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system
Eric M Bennett, Ruchi Anand, Paula W Allan, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2014
Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
L Nathan Tumey, Diane H Boschelli, Niala Bhagirath, et al.
Plos One
|
May 8, 2020
Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design
James R Apgar, Amy S P Tam, Rhady Sorm, et al.
The AAPS Journal
|
April 26, 2017
Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates
L Nathan Tumey, Fengping Li, Brian Rago, et al.
Molecular Cancer Therapeutics
|
August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers
Edmund I Graziani, Matthew Sung, Dangshe Ma, et al.
Page
of 3